Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-064519
Filing Date
2021-12-09
Accepted
2021-12-09 21:58:55
Documents
1
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3588
  Complete submission text file 0001213900-21-064519.txt   5026
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARS.COM, 300 S. RIVERSIDE PLAZA SUITE 1000 CHICAGO IL 60606
Business Address
McGovern Jr. Donald A. (Reporting) CIK: 0001706276 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 211483530